NVIV
Goldman Sachs’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,741
| Closed | -$5.22K | – | 5044 |
|
|
2024
Q1 | $5.22K | Buy |
+23,741
| New | +$5.22K | ﹤0.01% | 4668 |
|
|
2021
Q3 | – | Sell |
-40,123
| Closed | -$30K | – | 5751 |
|
|
2021
Q2 | $30K | Buy |
+40,123
| New | +$30K | ﹤0.01% | 5298 |
|
|
2018
Q1 | – | Sell |
-74,318
| Closed | -$57K | – | 4405 |
|
|
2017
Q4 | $57K | Buy |
74,318
+66
| +0.1% | – | ﹤0.01% | 4029 |
|
|
2017
Q3 | $108K | Sell |
74,252
-93,066
| -56% | -$135K | ﹤0.01% | 4029 |
|
|
2017
Q2 | $452K | Buy |
167,318
+98,879
| +144% | +$251K | ﹤0.01% | 3581 |
|
|
2017
Q1 | $277K | Sell |
68,439
-36,411
| -35% | -$139K | ﹤0.01% | 3820 |
|
|
2016
Q4 | $440K | Sell |
104,850
-95,443
| -48% | -$367K | ﹤0.01% | 3522 |
|
|
2016
Q3 | $1.36M | Sell |
200,293
-133,304
| -40% | -$867K | ﹤0.01% | 2891 |
|
|
2016
Q2 | $1.93M | Sell |
333,597
-15,711
| -4% | -$107K | ﹤0.01% | 2629 |
|
|
2016
Q1 | $2.44M | Buy |
349,308
+254,255
| +267% | +$1.8M | ﹤0.01% | 2417 |
|
|
2015
Q4 | $684K | Buy |
95,053
+51,116
| +116% | +$410K | ﹤0.01% | 3084 |
|
|
2015
Q3 | $379K | Buy |
43,937
+32,636
| +289% | +$190K | ﹤0.01% | 3474 |
|
|
2015
Q2 | $183K | Buy |
+11,301
| New | +$183K | ﹤0.01% | 4057 |
|